The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene on insulin sensitivity and insulin metabolism interact with size at birth

被引:126
作者
Eriksson, JG
Lindi, V
Uusitupa, M
Forsén, TJ
Laakso, M
Osmond, C
Barker, DJP
机构
[1] Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, FIN-00300 Helsinki, Finland
[2] Univ Kuopio, Dept Clin Nutr, FIN-70211 Kuopio, Finland
[3] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
[4] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
[5] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland
[6] Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton, Hants, England
关键词
D O I
10.2337/diabetes.51.7.2321
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes is known to be associated with a small body size at birth. Body size at birth is an indicator of the intrauterine environment. There is also a well-established association between the peroxisome proliferator-activated receptor (PPAR)-gamma2 gene and type 2 diabetes. We therefore assessed whether the effects of the Pro12Ala polymorphism of the PPAR-gamma2 gene on insulin sensitivity and insulin concentrations in adult life are modified by size at birth. We found that the effects of the Pro12Pro and Pro12Ala polymorphisms of the PPAR-gamma2 gene in elderly people depended on their body size at birth. The well-known association between small body size at birth and insulin resistance was seen only in individuals with the high-risk Pro12Pro allele. In those who had low birth weight, the Pro12Pro polymorphism of the PPAR-gamma2 gene was associated with increased insulin resistance (P < 0.002) and elevated insulin concentrations (P < 0.003). These interactions between the effects of the Pro12Ala polymorphisms of the PPAR-gamma2 gene on adult traits and the effects of birth weight link two previously unknown associations together within the context of type 2 diabetes. We suggest that these findings reflect gene-environment interaction.
引用
收藏
页码:2321 / 2324
页数:4
相关论文
共 25 条
[1]   RAT FETAL ENDOCRINE PANCREAS IN EXPERIMENTAL DIABETES [J].
AERTS, L ;
VANASSCHE, FA .
JOURNAL OF ENDOCRINOLOGY, 1977, 73 (02) :339-&
[2]   The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[3]   PPARγ, the ultimate thrifty gene [J].
Auwerx, J .
DIABETOLOGIA, 1999, 42 (09) :1033-1049
[4]  
BARKER DJP, 1989, LANCET, V2, P577
[5]   THE WELLCOME FOUNDATION LECTURE, 1994 - THE FETAL ORIGINS OF ADULT DISEASE [J].
BARKER, DJP .
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1995, 262 (1363) :37-43
[6]   The pleiotropic functions of peroxisome proliferator-activated receptor γ [J].
Debril, MB ;
Renaud, JP ;
Fajas, L ;
Auwerx, J .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (01) :30-47
[7]   A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity [J].
Deeb, SS ;
Fajas, L ;
Nemoto, M ;
Pihlajamäki, J ;
Mykkänen, L ;
Kuusisto, J ;
Laakso, M ;
Fujimoto, W ;
Auwerx, J .
NATURE GENETICS, 1998, 20 (03) :284-287
[8]   Birthweight, vitamin D receptor genotype and the programming of osteoporosis [J].
Dennison, EM ;
Arden, NK ;
Keen, RW ;
Syddall, H ;
Day, INM ;
Spector, TD ;
Cooper, C .
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2001, 15 (03) :211-219
[9]   Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells [J].
Dubois, M ;
Pattou, F ;
Kerr-Conte, J ;
Gmyr, V ;
Vandewalle, B ;
Desreumaux, P ;
Auwerx, J ;
Schoonjans, K ;
Lefebvre, J .
DIABETOLOGIA, 2000, 43 (09) :1165-1169
[10]   Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals [J].
Eriksson, JG ;
Forsén, T ;
Tuomilehto, J ;
Jaddoe, VWV ;
Osmond, C ;
Barker, DJP .
DIABETOLOGIA, 2002, 45 (03) :342-348